Results 231 to 240 of about 4,143,567 (308)
CCKBR (Gastrin Receptor) as a Theranostic Target in Oncology: Biological Rationale, Diagnostic Imaging, and Next-Generation Peptide-Based Drug Development. [PDF]
Chang MC +4 more
europepmc +1 more source
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach +9 more
wiley +1 more source
Effects of Endocannabinoid System Modulation on Cholinergic-Induced Anxiety-like Behaviors in Mice. [PDF]
Kruk-Slomka M +3 more
europepmc +1 more source
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang +9 more
wiley +1 more source
CEACAM1 participation in breast cancer progression
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin +3 more
wiley +1 more source
Plant peptide hormones: three decades of discovery and emerging paradigms. [PDF]
Torii KU.
europepmc +1 more source
Turning immune checkpoint inhibitors into synthetic switches for engineered T cells. [PDF]
Li YR.
europepmc +1 more source
IL18BP in cancer: a double-edged sword and emerging therapeutic opportunity. [PDF]
Huang C, Jiang Y, Wang N, Du B, Huang Q.
europepmc +1 more source

